Umedica Laboratories Private Limited Atorvastatin Export Data — India (DGFT 2022–2026)

Name: Umedica Laboratories Private Limited Atorvastatin Export Records India — #6 Exporter, 235 Shipments, $11.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Atorvastatin

India Pharmaceutical Trade Intelligence

$1.1B477 Suppliers145 CountriesHS 30049099

ExportsIndia → UNITED STATES52.5%India → CANADA25.9%

ImportsCROATIA → India$3.5M CANADA → India$2.5M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: APOTEX CORP

Umedica Laboratories Private Limited — Atorvastatin Exporter #6 | $11.8M Trade Value | TransData Nexus | TransData Nexus

Umedica Laboratories Private Limited — Atorvastatin Exporter Profile

Indian Pharmaceutical Exporter · #6 for Atorvastatin · $11.8M export value · DGFT Verified

Umedica Laboratories Private Limited is the #6 Indian exporter of Atorvastatin with $11.8M in export value and 235 verified shipments. Umedica Laboratories Private Limited holds a 1.1% market share in Atorvastatin exports across 8 countries. The company exports 11 pharmaceutical products worth $32.2M across 8 therapeutic categories.

Umedica Laboratories Private Limited — Atorvastatin Export Profile: Buyers & Destinations

Umedica Laboratories Private Limited Atorvastatin export treemap — buyers and destination countries | TransData Nexus

Where Does Umedica Laboratories Private Limited Export Atorvastatin?

Country	Value	Shipments	Share
UNITED STATES	$4.7M	148	65.6%
UNITED KINGDOM	$2.0M	71	28.8%
PHILIPPINES	$306.3K	22	4.3%
MAURITIUS	$42.1K	1	0.6%

Who Are the Top Buyers of Atorvastatin from Umedica Laboratories Private Limited?

Buyer	Country	Value	Orders
LIFESCIENCE LOGISTICS	UNITED STATES	$4.3M	138
CRESCENT PHARMA LTD.	UNITED KINGDOM	$774.1K	23
CRESCENT PHARMA LTD	UNITED KINGDOM	$691.4K	21
CRESCENT PHARMA LIMITED	UNITED KINGDOM	$576.0K	20
SUHITAS PHARMACEUTICALS INC	PHILIPPINES	$193.8K	13
NIVAGEN PHARMA	UNITED STATES	$115.9K	3
SUHITAS PHARMACEUTICALS INC.,	PHILIPPINES	$94.3K	7
LIFE SCIENCE LOGISTICS	UNITED STATES	$91.4K	2
LIFESCIENCE LOGISTICS,	UNITED STATES	$50.0K	1
TO THE ORDER	UNITED STATES	$50.0K	1

Umedica Laboratories Private Limited supplies Atorvastatin to 20 buyers globally. The largest buyer is LIFESCIENCE LOGISTICS (UNITED STATES), followed by CRESCENT PHARMA LTD. (UNITED KINGDOM) and CRESCENT PHARMA LTD (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Atorvastatin Formulations Does Umedica Laboratories Private Limited Export?

Product Description / Formulation	Value	Shipments
ATORVASTATIN CALCIUM TABLETS USP 40MG [PACK OF 1000 TABLETS]	$302.0K	11
ATORVASTATIN CALCIUM TABLETS USP 20MG [PACK OF 1000 TABLETS]	$265.0K	8
ATORVASTATIN CALCIUM TABLETS USP 40MG [P	$260.6K	6
ATORVASTATIN 80MG FILM COATED TABLETS (PACK OF 2X14 TABLETS)NOS	$243.0K	9
ATORVASTATIN CALCIUM TABLETS USP 80MG [P	$220.0K	6
ATORVASTATIN CALCIUM TABLETS USP 20MG [P	$203.8K	6
ATORVASTATIN CALCIUM TABLETS USP 40MG(EA	$200.0K	4
ATORVASTATIN CALCIUM TABLETS USP 20MG EACH TAB CONT ATORVASTATIN CALCIUM 20 718EQ TO ATORVASTATIN 20MG PACK OF 1000 TA	$184.3K	5
ATORVASTATIN 20MG FILM COATED TABLETS (PACK OF 2X14 TABLETS)NOS	$183.1K	6
ATORVASTATIN CALCIUM TABLETS USP 40MG EACH TAB CONT ATORVASTATIN CALCIUM 41 436EQ TO ATORVASTATIN 40MG PACK OF 1000 TA	$179.8K	4

Umedica Laboratories Private Limited exports 122 distinct Atorvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ATORVASTATIN CALCIUM TABLETS USP 40MG [PACK OF 1000 TABLETS] with 11 shipments worth $302.0K.

How Does Umedica Laboratories Private Limited Compare to Nearest Atorvastatin Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	ALKEM LABORATORIES LIMITED	$13.8M	277	5	$50.0K
11	MICRO LABS LIMITED	$13.7M	413	22	$33.2K
6	UMEDICA LABORATORIES PRIVATE LIMITED ★	$11.8M	235	8	$50.0K
12	BIOCON PHARMA LIMITED	$11.4M	229	2	$50.0K
15	ANNORA PHARMA PRIVATE LIMITED	$8.4M	426	1	$19.7K

Umedica Laboratories Private Limited ranks #6 among 477 Indian Atorvastatin exporters. Average shipment value of $50.0K compared to the market average of $657.7K. The closest competitors by value are ALKEM LABORATORIES LIMITED and MICRO LABS LIMITED.

Which Indian Ports Ship Atorvastatin Exports?

Port	Shipments	% Share
HYDERABAD ICD	2,042	13.6%
HYDERABAD ICD (INSNF6)	1,131	7.5%
NHAVA SHEVA SEA (INNSA1)	842	5.6%
SAHAR AIR	839	5.6%
JNPT/ NHAVA SHEVA SEA	779	5.2%
DELHI AIR	613	4.1%
SAHAR AIR CARGO ACC (INBOM4)	581	3.9%
HYDERABAD AIR	554	3.7%

Geopolitical & Trade Policy Impact on Umedica Laboratories Private Limited's Atorvastatin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Umedica Laboratories. The Israel-Iran conflict has led to disruptions in Middle East trade routes, particularly affecting the Red Sea shipping lanes. Major shipping lines have imposed 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, effectively increasing the cost of exporting goods through these routes. This escalation in shipping costs can erode profit margins and necessitate strategic adjustments in logistics and pricing strategies. (sgeexport.com)

Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian goods by the US, including a 25% tariff announced in 2025, poses a significant challenge. This tariff could lead to increased costs for Indian pharmaceutical products in the US market, potentially affecting demand and profitability. (en.wikipedia.org)

The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a promising avenue for Umedica. The FTA eliminates tariffs on Indian pharmaceutical exports to the EU, providing a competitive advantage and facilitating market expansion. This agreement is expected to open a market worth $572.3 billion for Indian pharmaceutical and MedTech exports to Europe from 2027 onward. (mordorintelligence.com)

Umedica Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have stringent Good Manufacturing Practice (GMP) requirements. Historically, non-compliance has led to import bans and reputational damage for Indian firms. For instance, in 2013, the FDA banned imports from certain Indian pharmaceutical companies due to GMP violations, highlighting the critical importance of adherence to quality standards. (comcec.org)

While specific regulatory events concerning Umedica Laboratories are not detailed in the available data, the company's sustained export performance suggests a commitment to maintaining high-quality standards and compliance with international regulations. Continuous investment in quality control systems and regulatory compliance is essential to navigate the evolving landscape and to capitalize on global market opportunities.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Atorvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Umedica Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 259 individual customs records matching Umedica Laboratories Private Limited exporting Atorvastatin, covering 122 formulations to 8 countries via 20 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 145+ countries, 1,291+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Atorvastatin

Atorvastatin

Umedica Laboratories Private Limited — Atorvastatin Exporter Profile

Umedica Laboratories Private Limited — Atorvastatin Export Profile: Buyers & Destinations

Where Does Umedica Laboratories Private Limited Export Atorvastatin?

Who Are the Top Buyers of Atorvastatin from Umedica Laboratories Private Limited?

What Is India's Total Atorvastatin Export Value and How Much Does Umedica Laboratories Private Limited Contribute?

What Is the Average Shipment Value for Umedica Laboratories Private Limited's Atorvastatin Exports?

How Does Umedica Laboratories Private Limited Compare to Other Indian Atorvastatin Exporters?

What Atorvastatin Formulations Does Umedica Laboratories Private Limited Export?

Regulatory Requirements: Exporting Atorvastatin to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Umedica Laboratories Private Limited Compare to Nearest Atorvastatin Exporters?

Which Indian Ports Ship Atorvastatin Exports?

What Other Cardiovascular Products Does Umedica Laboratories Private Limited Export?

Geopolitical & Trade Policy Impact on Umedica Laboratories Private Limited's Atorvastatin Exports

Umedica Laboratories Private Limited — Regulatory Compliance & Quality Standards

About Umedica Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Atorvastatin Export Data from Umedica Laboratories Private Limited

Atorvastatin Stats

Company Overview

Top Products by Umedica Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source